戻る
Johnson & Johnson (JNJ)価格
JNJ 株価推移チャート
JNJ 収入
Johnson & Johnson
$218.21
-0.2%
$-0.44
終値： Jan 20, 16:00:00 GMT-5
$217.49
-0.32%
$-0.71
アフターマーケット：Jan 20, 20:28:34 GMT-5
B+
最終スコア
主要データ
前終値
$218.66
始値
$217.09
当日レンジ
$214.5 - $218.72
52週レンジ
$141.5 - $220.11
取引高
10.2M
平均取引高
8.5M
1株当たり利益(TTM)
10.36
配当利回り
2.46%
時価総額
$524.0B
JNJとは何ですか？
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. The company is headquartered in New Brunswick, New Jersey and currently employs 138,100 full-time employees. The Company’s segments include Innovative Medicine and MedTech. The Innovative Medicine segment is focused on various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, cardiovascular and metabolism. Its products include REMICADE (infliximab), SIMPONI (golimumab), SIMPONI ARIA (golimumab), STELARA (ustekinumab), TREMFYA (guselkumab), EDURANT (rilpivirine), and INVEGA SUSTENNA/XEPLION (paliperidone palmitate). The MedTech segment includes a portfolio of products used in cardiovascular, orthopedics, surgery, and vision categories. The Cardiovascular portfolio includes electrophysiology products to treat heart rhythm disorders and circulatory restoration products (Shockwave) for the treatment of calcified coronary artery disease (CAD) and peripheral artery disease (PAD).